Sugi Predict

Sugi Predict / Targets / MAP7

MAP7

Ensconsin · Q14244 · MAP7 on Sugi Atlas →

0 patent compounds predicted against MAP7, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to MAP7 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
L-Arginine Role for Stone Lower Ureter : A Randomized Control Study PHASE4COMPLETED
Molecular Mechanisms of Type 2 Diabetes Mellitus PHASE4COMPLETED
Neuroprotectant for Hypertensive Intracerebral Hemorrhage PHASE3UNKNOWN
Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome PHASE3COMPLETED
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) PHASE2/PHASE3ACTIVE_NOT_RECRUITING
A Multicenter Study of NAP (AL-108) in Schizophrenia PHASE2COMPLETED
Safety and Efficacy of AAV9/AP4B1 (BFB-101) For Patients With AP4B1-related Hereditary Spastic Paraplegia Type 47 (SPG47) PHASE1/PHASE2NOT_YET_RECRUITING
Breakpoint Analysis of de Novo Apparently Balanced Chromosomal Translocations EARLY_PHASE1UNKNOWN
Enhanced Linkage Maps From Family-Based Genetics Studies nanCOMPLETED
Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others nanRECRUITING
Generating Intervals of Reference FFor Early Life Brain Biomarkers. nanRECRUITING
Genetic Study of Familial Epilepsy nanCOMPLETED
Identification of New FTLD Genes nanUNKNOWN
Identification Genetic, Immunologic and Microbial Markers of Hirschsprung Associated Enterocolitis in Children With Hirschsprung Disease nanUNKNOWN
Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease nanRECRUITING
NTRK 1,2,3 Rearrangements in Patients With Solid Tumors nanACTIVE_NOT_RECRUITING
The Enteric Nervous System in Spinal Cord Injury: Study of the Enteric Nervous System and the Intestinal Epithelial Barrier Via Colonic Biopsies in Spinal Cord Injury Patients nanRECRUITING
Genes of Hypertension in African Americans nanCOMPLETED
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome nanRECRUITING
Identification of an Asthma Susceptibility Gene on 3P nanCOMPLETED
Human Epilepsy Genetics--Neuronal Migration Disorders Study nanRECRUITING
Mapping of Tumor Stem Cells in the Resection Marigin During Extirpation of Highly Malignant Gliomas Using GlioStem nanUNKNOWN
Protein Synthesis in the Brain of Patients With Fragile X Syndrome nanCOMPLETED
Diagnostic of Chemotherapy Induced Neuropathy in Children nanCOMPLETED
Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia nanRECRUITING
Longitudinal Biomarkers With Selected Outcome Measures In CMT nanRECRUITING
Disability Severity Scale (DSI) and Hereditary Motor and Sensory Neuropathy Overall Disability Scale (HMSN-R-ODS) nanCOMPLETED
Natural History Study of Smith-Magenis Syndrome nanACTIVE_NOT_RECRUITING
Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial nanRECRUITING
Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a MAP7 binder may also engage these)

ProteinNameSimilarity
O88735 — 1.000 O88735 →
Q5ZIA2 — 1.000 Q5ZIA2 →
Q96T17 — 0.996 Q96T17 →
D4A4L4 — 0.996 D4A4L4 →
A2AJI0 — 0.993 A2AJI0 →
Q9WU62 — 0.993 Q9WU62 →
Q3KQU3 — 0.992 Q3KQU3 →
INCENP Inner centromere protein 0.992 landscape →
Q5R7F9 — 0.991 Q5R7F9 →
A0A8I5ZM56 — 0.990 A0A8I5ZM56 →
Q5RG44 — 0.990 Q5RG44 →
Q99LJ0 — 0.989 Q99LJ0 →
Q6PCQ0 — 0.988 Q6PCQ0 →
A2AG50 — 0.988 A2AG50 →
A1X157 — 0.987 A1X157 →
Q9Y2H5 — 0.987 Q9Y2H5 →
Q5REG6 — 0.987 Q5REG6 →
Q09YG9 — 0.987 Q09YG9 →
Q9ERH4 — 0.987 Q9ERH4 →
Q00PJ1 — 0.987 Q00PJ1 →
Q09YJ3 — 0.987 Q09YJ3 →
A0M8T5 — 0.986 A0M8T5 →
Q2IBA2 — 0.986 Q2IBA2 →
Q09YK4 — 0.986 Q09YK4 →
E9QG33 — 0.986 E9QG33 →
Q5PR69 — 0.986 Q5PR69 →
NFRKB Nuclear factor related to kappa-B-binding protein 0.986 landscape →
Q9Y6A5 — 0.986 Q9Y6A5 →
O46385 — 0.986 O46385 →
Q09YM8 — 0.986 Q09YM8 →